Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Renal Denervation Using the Vessix Renal Denervation System for the Treatment of Hypertension (REDUCE HTN:REINFORCE)

ClinicalTrials.gov ID: NCT02392351

Public ClinicalTrials.gov record NCT02392351. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 4:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Boston Scientific Clinical Trial of Renal Denervation Using the Vessix Reduce™ Catheter and Vessix™ Generator for the Treatment of HyperTensioN: REINFORCE

Study identification

NCT ID
NCT02392351
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Boston Scientific Corporation
Industry
Enrollment
51 participants

Conditions and interventions

Conditions

Interventions

  • Renal Denervation (Vessix) Device
  • Renal Angiography Device

Device

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2015
Primary completion
Sep 6, 2017
Completion
Aug 1, 2019
Last update posted
Feb 10, 2021

2015 – 2019

United States locations

U.S. sites
12
U.S. states
11
U.S. cities
11
Facility City State ZIP Site status
Cardiology, PC Birmingham Alabama 35211
Cedars - Sinai Medical Center Los Angeles California 90048
Mount Sinai Medical Center Miami Beach Florida 33140
Cardiovascular Institute of the South Houma Louisiana 70360
University of Maryland Baltimore Maryland 21201
Tufts Medical Center Boston Massachusetts 02111
Columbia University Medical Center New York New York 10032
Albert Einstein Medical Center Philadelphia Pennsylvania 19141
Wellmont CVA Heart Institute Kingsport Tennessee 37660
Dallas Medical Center Dallas Texas 75006
Cardiovascular Research Institute of Dallas Dallas Texas 75231
Aspirus Heart and Vascular Institute Wausau Wisconsin 54401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02392351, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 10, 2021 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02392351 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →